Cases & Deals

Celgene pursues patent infringement litigation against KV Pharmaceutical concerning Ritalin LA®

Clients Celgene Corporation

Jones Day represents Celgene Corporation in a Hatch-Waxman patent infringement case concerning a generic version of the branded drug Ritalin LA®.

Celgene Corporation et al. v. KV Pharmaceutical Co., Case No. 2-07-cv-04819 (D.N.J. 2007) (Judge Wigenton)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.